Shannon Frey
Family · Wendell, NCNPI 1720691298
Payments from drug & device makers
Across 85 payments — averaging $17.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$293
- Gilead$215
- AbbVie$105
- Lilly USA, LLC$99
- Boehringer Ingelheim$97
- AstraZeneca$78
- plus $575 from 18 others
What the payments were for
- Food & beverage$1,461100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 18 | $293 |
| Gilead | 10 | $215 |
| AbbVie | 6 | $105 |
| Lilly USA, LLC | 7 | $99 |
| Boehringer Ingelheim | 5 | $97 |
| AstraZeneca | 5 | $78 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $69 |
| Boston Scientific | 2 | $63 |
| Merck | 4 | $63 |
| GSK | 4 | $62 |
| Exact Sciences | 3 | $53 |
| Bayer | 2 | $36 |
| Amgen | 2 | $31 |
| Biogen | 2 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Medtronic | 1 | $19 |
| Pfizer | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Johnson & Johnson | 1 | $16 |
| Novartis | 1 | $15 |
| Exeltis, USA Inc. | 1 | $14 |
| Almatica Pharma LLC | 1 | $14 |
| Irhythm Technologies, Inc. | 1 | $13 |
How this compares
$1,461 in reported general payments places this provider in the 75th percentile of 4,522 family providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Colchicine | 11 | $682 |
| Gabapentin | 26 | $474 |
| Atorvastatin Calcium | 63 | $356 |
| Tramadol Hcl | 11 | $350 |
| Levothyroxine Sodium | 23 | $286 |
| Pantoprazole Sodium | 28 | $216 |
| Amlodipine Besylate | 66 | $203 |
| Omeprazole | 32 | $188 |
| Lisinopril | 52 | $180 |
| Losartan Potassium | 26 | $159 |
| Tamsulosin Hcl | 33 | $144 |
| Oxybutynin Chloride ErOxybutynin Chloride | 13 | $131 |
| Rosuvastatin Calcium | 17 | $117 |
| Metoprolol Succinate | 21 | $78 |
| Sertraline Hcl | 31 | $59 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Almatica Pharma LLCSertraline Hcl | $14 | $5931 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,522 family providers in North Carolina.
Other family in Wendell
- Leslie ByrneFayetteville$482K
- Michele CerraRaleigh$332K
- Anne LakeArchdale$306K
- Carrie PettitRaleigh$298K
- Nicole RothmanDurham$268K
- Meredith LeaYanceyville$253K
- Jennifer GibbsRaleigh$216K
- Juanita PerkinsDurham$213K
- Teresa DossWilmington$137K
- Debra ScottCharlotte$129K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.